Engineered amylase variants
US12071642B2 · kind B2 · utility
0Cited by
138References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 6, 2023 |
| Grant date | Aug 27, 2024 |
| Priority date | — |
| Expiry date | Sep 6, 2043 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02E50/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides engineered amylase polypeptides and compositions thereof. The engineered amylase polypeptides have been optimized to provide improved thermostability, protease stability, and stability under a range of pH conditions, including acidic (pH<7) conditions. The invention also relates to the use of the compositions comprising the engineered amylase polypeptides for therapeutic and/or nutritional purposes. The present invention also provides polynucleotides encoding the engineered amylase polypeptides, as well as methods for making the engineered polynucleotides and amylase polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.